health AI-Designed Universal Vaccine Successfully Completes First Human Clinical Trial
Researchers from Cambridge and Southampton unveil an AI-created universal vaccine targeting Sarbeco coronaviruses, marking a pivotal shift from reactive to proactive pandemic defense.
